Worth reading
55In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
138094
Rights (121,164 31st Stock Acquisition Rights and 16,930 32nd Stock Acquisition Rights)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Acquisition and cancellation of the 31st Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) and the 32nd Stock Acquisition Rights, and the monthly exercise status report for the 31st Stock Acquisition Rights
Intended allottee
Cantor Fitzgerald Europe (at the time of issuance on 19 November 2025)
発行済株式総数
0% (0 shares delivered during the month; exercise ratio: -)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥72.9 for the 31st Stock Acquisition Rights (exercise price during the month under review). Details of the adjustment provisions and the adjustment floor: not disclosed
Number of Stock Acquisition Rights
31st Stock Acquisition Rights: 121,164 acquired and cancelled; 0 remaining after cancellation. 32nd Stock Acquisition Rights: 16,930 acquired and cancelled; 0 remaining after cancellation. Unexercised 31st Stock Acquisition Rights: 121,164 at the end of the month preceding the month under review and 0 at the end of the month under review
Procedures under the Corporate Code of Conduct
The disclosure states the status of compliance with the exercise restrictions under Article 434 of the Listing Regulations. The number of shares delivered for all series combined was 0, the number of listed shares as of the payment date for the issuance was 19,494,600, and the exercise ratio subject to the exercise restrictions was -
Most recent equity financing
19 November 2025: Issuance of the 31st and 32nd Stock Acquisition Rights, with Cantor Fitzgerald Europe as the allottee (the detailed amount is not stated in this document)
| Item | Details |
|---|---|
| Type of issuance or disposal | Acquisition and cancellation of the 31st Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) and the 32nd Stock Acquisition Rights, and the monthly exercise status report for the 31st Stock Acquisition Rights |
| Intended allottee | Cantor Fitzgerald Europe (at the time of issuance on 19 November 2025) |
| Dilution Rate | 0% (0 shares delivered during the month; exercise ratio: -) |
| Total number of issued shares | 20,004,600 shares (as of the end of the month preceding the month under review) → 20,004,600 shares (as of the end of the month under review; 0 shares delivered)（0%） |
| Exercise price | ¥72.9 for the 31st Stock Acquisition Rights (exercise price during the month under review). Details of the adjustment provisions and the adjustment floor: not disclosed |
| Number of Stock Acquisition Rights | 31st Stock Acquisition Rights: 121,164 acquired and cancelled; 0 remaining after cancellation. 32nd Stock Acquisition Rights: 16,930 acquired and cancelled; 0 remaining after cancellation. Unexercised 31st Stock Acquisition Rights: 121,164 at the end of the month preceding the month under review and 0 at the end of the month under review |
| Procedures under the Corporate Code of Conduct | The disclosure states the status of compliance with the exercise restrictions under Article 434 of the Listing Regulations. The number of shares delivered for all series combined was 0, the number of listed shares as of the payment date for the issuance was 19,494,600, and the exercise ratio subject to the exercise restrictions was - |
| Most recent equity financing | 19 November 2025: Issuance of the 31st and 32nd Stock Acquisition Rights, with Cantor Fitzgerald Europe as the allottee (the detailed amount is not stated in this document) |
Items this document does not state (20)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.All remaining Stock Acquisition Rights outstanding on the acquisition date were acquired and cancelled. No specific reason for the acquisition and cancellation was disclosed.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.